Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
36,785,323
-
Shares change
-
-567,256
-
Total reported value, excl. options
-
$1,799,227,912
-
Value change
-
-$45,286,683
-
Put/Call ratio
-
114%
-
Number of buys
-
76
-
Number of sells
-
-77
-
Price
-
$48.91
Significant Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q2 2016
185 filings reported holding RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK as of Q2 2016.
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,785,323 shares
of 95,963,102 outstanding shares and own 38.3% of the company stock.
Largest 10 shareholders include FMR LLC (5,847,783 shares), Capital Research Global Investors (4,778,169 shares), WELLINGTON MANAGEMENT GROUP LLP (4,188,184 shares), VANGUARD GROUP INC (2,589,718 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,591,977 shares), BlackRock Fund Advisors (1,390,985 shares), WELLS FARGO & COMPANY/MN (1,348,155 shares), STATE STREET CORP (1,268,686 shares), BlackRock Institutional Trust Company, N.A. (879,001 shares), and COLUMBIA WANGER ASSET MANAGEMENT LLC (863,392 shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.